thalidomide has been researched along with EBV Infections in 11 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recurrent erythema multiforme is a rare disorder, clinically characterized by symmetrically distributed, erythematous, and bullous skin and mucous lesions, mainly precipitated by a preceding herpes simplex infection." | 6.42 | Thalidomide as elective treatment in persistent erythema multiforme; report of two cases. ( Conejo-Mir, JS; del Canto, S; Hernandez, C; Muñoz, MA; Pulpillo, A; Rodríguez-Freire, L; Serrano, A, 2003) |
| "Lenalidomide, thalidomide, and pomalidomide (LTP) are immunomodulatory agents approved for use in multiple myeloma, but in some settings, especially with alkylating agents, an increase in Hodgkin lymphoma and other secondary primary malignancies (SPM) has been noted." | 3.83 | Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression. ( Baladandayuthapani, V; Dawson, CW; Iempridee, T; Jones, RJ; Kenney, SC; Lee, HC; Lin, HC; Mertz, JE; Orlowski, RZ; Shah, JJ; Wang, X; Weber, DM, 2016) |
| "Recurrent erythema multiforme is a rare disorder, clinically characterized by symmetrically distributed, erythematous, and bullous skin and mucous lesions, mainly precipitated by a preceding herpes simplex infection." | 2.42 | Thalidomide as elective treatment in persistent erythema multiforme; report of two cases. ( Conejo-Mir, JS; del Canto, S; Hernandez, C; Muñoz, MA; Pulpillo, A; Rodríguez-Freire, L; Serrano, A, 2003) |
| "Chronic enterocolitis is rare in infancy and accounts for less than 0." | 1.33 | Long-term outcome of intractable ulcerating enterocolitis of infancy. ( Lindley, KJ; Milla, PJ; Ramsay, AD; Shah, N; Thapar, N, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, YY | 1 |
| Au-Yeung, R | 1 |
| Lau, HP | 1 |
| Kwong, YL | 1 |
| Xia, B | 1 |
| Wang, X | 2 |
| Yang, R | 1 |
| Mengzhen, L | 1 |
| Yang, K | 1 |
| Ren, L | 1 |
| Li, S | 1 |
| Wang, S | 1 |
| Zhang, Y | 1 |
| Quintanilla-Martinez, L | 1 |
| Ridaura, C | 1 |
| Nagl, F | 1 |
| Sáez-de-Ocariz, M | 1 |
| Durán-McKinster, C | 1 |
| Ruiz-Maldonado, R | 1 |
| Alderete, G | 1 |
| Grube, P | 1 |
| Lome-Maldonado, C | 1 |
| Bonzheim, I | 1 |
| Fend, F | 1 |
| Läubli, H | 1 |
| Tzankov, A | 1 |
| Juskevicius, D | 1 |
| Degen, L | 1 |
| Rochlitz, C | 1 |
| Stenner-Liewen, F | 1 |
| Jones, RJ | 1 |
| Iempridee, T | 1 |
| Lee, HC | 1 |
| Mertz, JE | 1 |
| Kenney, SC | 1 |
| Lin, HC | 1 |
| Baladandayuthapani, V | 1 |
| Dawson, CW | 1 |
| Shah, JJ | 1 |
| Weber, DM | 1 |
| Orlowski, RZ | 1 |
| Schmit, JM | 1 |
| DeLaune, J | 1 |
| Norkin, M | 1 |
| Grosbach, A | 1 |
| Iannitto, E | 1 |
| Ferreri, AJ | 1 |
| Minardi, V | 1 |
| Tripodo, C | 1 |
| Kreipe, HH | 1 |
| Ninan, MJ | 1 |
| Datta, YH | 1 |
| Chim, CS | 1 |
| Choi, PT | 1 |
| Lee, WK | 1 |
| Conejo-Mir, JS | 1 |
| del Canto, S | 1 |
| Muñoz, MA | 1 |
| Rodríguez-Freire, L | 1 |
| Serrano, A | 1 |
| Hernandez, C | 1 |
| Pulpillo, A | 1 |
| Thapar, N | 1 |
| Shah, N | 1 |
| Ramsay, AD | 1 |
| Lindley, KJ | 1 |
| Milla, PJ | 1 |
3 reviews available for thalidomide and EBV Infections
| Article | Year |
|---|---|
Angioimmunoblastic T-cell lymphoma.
Topics: B-Lymphocytes; CD4-Positive T-Lymphocytes; Cell Proliferation; Dendritic Cells; Epstein-Barr Virus I | 2008 |
Post-transplant lymphoproliferative disorder presenting as multiple myeloma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy | 2010 |
Thalidomide as elective treatment in persistent erythema multiforme; report of two cases.
Topics: Adult; Epstein-Barr Virus Infections; Erythema Multiforme; Female; Humans; Middle Aged; Thalidomide | 2003 |
8 other studies available for thalidomide and EBV Infections
| Article | Year |
|---|---|
Complete response of age-related Epstein-Barr virus-associated polymorphic nodal lymphoproliferative disease of plasmacytic type to low-dose lenalidomide.
Topics: Aged, 80 and over; Aging; Antigens, CD; Epstein-Barr Virus Infections; Humans; Immunocompromised Hos | 2018 |
Epstein-Barr virus infection is associated with clinical characteristics and poor prognosis of multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cells, Cultured; DNA, Viral; Epstein-Bar | 2019 |
Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.
Topics: Adolescent; Child; Child, Preschool; Epstein-Barr Virus Infections; Female; Follow-Up Studies; Herpe | 2013 |
Lenalidomide monotherapy leads to a complete remission in refractory B-cell post-transplant lymphoproliferative disorder.
Topics: Adult; B-Lymphocytes; Biopsy; Epstein-Barr Virus Infections; Female; Genomics; Hematopoietic Stem Ce | 2016 |
Lenalidomide, Thalidomide, and Pomalidomide Reactivate the Epstein-Barr Virus Lytic Cycle through Phosphoinositide 3-Kinase Signaling and Ikaros Expression.
Topics: Animals; Cell Line, Tumor; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Humans; Ikaros Trans | 2016 |
A Case of Plasmablastic Lymphoma Achieving Complete Response and Durable Remission after Lenalidomide-Based Therapy.
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Computed Tomography Angiography; | 2017 |
Hodgkin's lymphoma as a second cancer in multiple myeloma never exposed to lenalidomide.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Boronic Acids; Bortezomib; Combined Modal | 2013 |
Long-term outcome of intractable ulcerating enterocolitis of infancy.
Topics: Adolescent; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Colectomy; Colitis, Ulcer | 2005 |